Type 2 Diabetes: Vicadrostat and Empagliflozin Study

We are testing the combination of vicadrostat and empagliflozin in people with type 2 diabetes, high blood pressure, and heart disease. The goal is to see if this combination can improve heart health compared to a placebo.

>2 yearsConfirmation phase (III)Cost ReimbursementPartially RemoteInvestigational MedicinesOralCardiologyEndocrinologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Jardiance
Jardiance is a medicine that helps lower blood sugar in adults with type 2 diabetes.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Canagliflozin Monohydrate
Canagliflozin monohydrate is a substance that helps lower blood sugar in people with type 2 diabetes.
Empagliflozin
Empagliflozin is a substance that helps lower blood sugar in people with type 2 diabetes by increasing sugar removal in the urine.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Bi 690517

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Empagliflozin Krka
Empagliflozin Polpharma
Empaglifozin

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Medical University Of Graz
University Clinic for Internal Medicine, Clinical Department for Cardiology
Graz, Austria
Stadt Wien Wiener Gesundheitsverbund
Cardiology Dept
Langenzersdorf, Austria
Klinik Hietzing
Abtlg. für Innere Medizin
Perchtoldsdorf, Austria
Sponsor: Boehringer Ingelheim International GmbH
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.